Imunon IMNN
NASDAQ IMNN
$1.28 -0.04 (-3.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Imunon (IMNN) Amortization of Deferred Charges (2012 - 2013)

Updated

Imunon (IMNN) reported Amortization of Deferred Charges of -$5,189 for Q3 2013, compared with -$3,829 a year earlier.

Analysis

Imunon (IMNN) Amortization of Deferred Charges (2012 - 2013) Analysis & Trends

Over the twelve months ended Sep 30, 2013, Imunon's Amortization of Deferred Charges came in at -$17,581; for FY2011, it was $65,467.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Imunon 5.97 Mn 5.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -5,189.00
Jun 30, 2013 -4,734.00
Mar 31, 2013 -3,829.00
Sep 30, 2012 -3,829.00
Jun 30, 2012 -2,553.00
Mar 31, 2012 65,467.00
API Access

Imunon Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IMNN&period=max&api_key=YOUR_API_KEY